Anzeige
Erschienen in:
01.05.2020 | Neuro-oncology (Y Umemura, Section Editor)
Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement
Erschienen in: Current Oncology Reports | Ausgabe 5/2020
Einloggen, um Zugang zu erhaltenAbstract
Purpose of Review
Real-world data (RWD) applications in healthcare that support learning health systems and pragmatic clinical trials are gaining momentum, largely due to legislation supporting real-world evidence (RWE) for drug approvals. Clinical notes are thought to be the cornerstone of RWD applications, particularly for conditions with limited effective treatments, extrapolation of treatments from other conditions, or heterogenous disease biology and clinical phenotypes.
Recent Findings
Here, we discuss current issues in applying RWD captured at the point-of-care and provide a framework for clinicians to engage in RWD collection. To achieve clinically meaningful results, RWD must be reliably captured using consistent terminology in the description of our patients.
Summary
RWD complements traditional clinical trials and research by informing the generalizability of results, generating new hypotheses, and creating a large data network for scientific discovery. Effective clinician engagement in the development of RWD applications is necessary for continued progress in the field.